Famotidine
NDC Package 12634-967-01

11-digit billing NDC: 12634096701

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Famotidine is tablets USP are indicated in:1. Marketed by Apotheca Inc., this product is identified by NDC 12634-967 and is authorized under FDA application ANDA075511.

Identification & Billing

NDC Package Code
12634-967-01
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
12634096701
RxNorm Crosswalk
RxCUI: 310273 - famotidine 20 MG Oral Tablet

Clinical Specifications

Proprietary Name
Famotidine
Dosage Form
-
Usage Information
Famotidine tablets USP are indicated in:1. Short-term treatment of active duodenal ulcerMost adult patients heal within 4 weeks; there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks. Studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks.2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcerControlled studies in adults have not extended beyond one year.3. Short-term treatment of active benign gastric ulcerMost adult patients heal within 6 weeks. Studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks.4. Short-term treatment of gastroesophageal reflux disease (GERD)Famotidine tablets USP are indicated for short-term treatment of patients with symptoms of GERD (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies). Famotidine tablets are also indicated for the short-term treatment of esophagitis due to GERD including erosive or ulcerative disease diagnosed by endoscopy (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies). 5. Treatment of pathological hypersecretory conditions(e.g., Zollinger-Ellison Syndrome, multiple endocrine adenomas) (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies).

Regulatory & Marketing

Labeler Name
Apotheca Inc.
FDA Application #
ANDA075511
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-16-2001
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (12634-967). Click a package code to view its specific billing and regulatory data.

30 TABLET, FILM COATED in 1 BOTTLE
20 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12634-967-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Famotidine, labeled by Apotheca Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apotheca Inc. on April 16, 2001. The current certification is valid through December 31, 2019.

How is this Apotheca Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12634096701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12634-967-01
11-Digit CMS (5-4-2)
12634-0967-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.